The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact
Open accessAbstract
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized by an acute deterioration in respiratory symptoms, are fundamental events impacting negatively upon disease progression, comorbidities, wellbeing and mortality. ECOPD also represent the largest component of the socioeconomic burden of COPD. ECOPDs are currently defined as acute worsening of respiratory symptoms that require additional therapy. Definitions that require worsening of dyspnoea and sputum volume/purulence assume that acute infections, especially respiratory viral infections, and/or exposure to pollutants are the main cause of ECOPD. But other factors may contribute to ECOPD, such as the exacerbation of other respiratory diseases and non‐respiratory diseases (e.g., heart failure, thromboembolism). The complexity of worsening dyspnoea has suggested a need to improve the definition of ECOPD using objective measurements such as blood counts and C‐reactive protein to improve accuracy of diagnosis and a personalized approach to management. There are three time points when we can intervene to improve outcomes: acutely, to attenuate the length and severity of an established exacerbation; in the aftermath, to prevent early recurrence and readmission, which are common, and in the long‐term, establishing preventative measures that reduce the risk of future events. Acute management includes interventions such as corticosteroids or antibiotics and measures to support the respiratory system, including non‐invasive ventilation (NIV). Current therapies are broad and better understanding of clinical phenotypes and biomarkers may help to establish a more tailored approach, for example in relation to antibiotic prescription. Other unmet needs include effective treatment for viruses, which commonly cause exacerbations. Preventing early recurrence and readmission to hospital is important and the benefits of interventions such as antibiotics or anti‐inflammatories in this period are not established. Domiciliary NIV in those patients who are persistently hypercapnic following discharge and pulmonary rehabilitation can have a positive impact. For long‐term prevention, inhaled therapy is key. Dual bronchodilators reduce exacerbation frequency but in patients with continuing exacerbations, triple therapy should be considered, especially if blood eosinophils are elevated. Other options include phosphodiesterase inhibitors and macrolide antibiotics. ECOPD are a key component of the assessment of COPD severity and future outcomes (quality of life, hospitalisations, health care resource utilization, mortality) and are a central component in pharmacological management decisions. Targeted therapies directed towards specific pathways of inflammation are being explored in exacerbation prevention, and this is a promising avenue for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Self-citationDonaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
Esteban, A. (2002) · JAMA · doi:10.1001/jama.287.3.345 · Cited by 1,779
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Self-citationOnce-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, D. A., Barnhart, F., Brealey, N., Brooks, J., Criner, G. J., Day, N. C., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Jones, C. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713901 · Cited by 1,253
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
Self-citationNew Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Self-citationPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Puhan, M. A., Gimeno-Santos, E., Cates, C. J., & Troosters, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005305.pub4 · Cited by 991
Toward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105482 · Cited by 963
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Self-citationAlqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233147 · Cited by 858
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
Self-citationWaljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Self-citationWedzicha, J. A., Calverley, P. M. A., Seemungal, T. A., Hagan, G., Ansari, Z., & Stockley, R. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-973oc · Cited by 827
Self-citationTriple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Rabe, K. F., Martinez, F. J., Ferguson, G. T., Wang, C., Singh, D., Wedzicha, J. A., Trivedi, R., St. Rose, E., Ballal, S., McLaren, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916046 · Cited by 690
Self-citationPhysical Activity and Hospitalization for Exacerbation of COPD
Pitta, F., Troosters, T., Probst, V. S., Spruit, M. A., Decramer, M., & Gosselink, R. (2006) · Chest · doi:10.1378/chest.129.3.536 · Cited by 688
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Self-citationClinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
Woodruff, P. G., Barr, R. G., Bleecker, E., Christenson, S. A., Couper, D., Curtis, J. L., Gouskova, N. A., Hansel, N. N., Hoffman, E. A., Kanner, R. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505971 · Cited by 684
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00791-2016 · Cited by 683
Self-citationEffectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 656
Murphy, P. B., Rehal, S., Arbane, G., Bourke, S., Calverley, P. M. A., Crook, A. M., Dowson, L., Duffy, N., Gibson, G. J., Hughes, P. D., et al. (2017) · JAMA · doi:10.1001/jama.2017.4451 · Cited by 654
Self-citationMepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., Martinot, J.-B., Sagara, H., Albers, F. C., Bradford, E. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708208 · Cited by 625
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Papi, A., Vestbo, J., Fabbri, L., Corradi, M., Prunier, H., Cohuet, G., Guasconi, A., Montagna, I., Vezzoli, S., Petruzzelli, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30206-x · Cited by 603
Self-citationBrightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
The Asthma–COPD Overlap Syndrome
Postma, D. S., & Rabe, K. F. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1411863 · Cited by 548
Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD
Stockley, R. A., O’Brien, C., Pye, A., & Hill, S. L. (2000) · Chest · doi:10.1378/chest.117.6.1638 · Cited by 535
Wedzicha, J. A., Decramer, M., Ficker, J. H., Niewoehner, D. E., Sandström, T., Taylor, A. F., D'Andrea, P., Arrasate, C., Chen, H., & Banerji, D. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70052-3 · Cited by 535
Self-citationAppendini, L., Patessio, A., Zanaboni, S., Carone, M., Gukov, B., Donner, C. F., & Rossi, A. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173743 · Cited by 515
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010) · Chest · doi:10.1378/chest.09-2029 · Cited by 514
Self-citationAustin, M. A., Wills, K. E., Blizzard, L., Walters, E. H., & Wood-Baker, R. (2010) · BMJ · doi:10.1136/bmj.c5462 · Cited by 510
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Air pollution and airway disease
Kelly, F. J., & Fussell, J. C. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03776.x · Cited by 478
Spruit, M. A. (2003) · Thorax · doi:10.1136/thorax.58.9.752 · Cited by 476
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Self-citationUpdate on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Celli, B. R., & Wedzicha, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900500 · Cited by 461
Self-citationLung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D., Miller, B. E., Tal-Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 459
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Self-citationFunctional effects of the microbiota in chronic respiratory disease
Budden, K. F., Shukla, S. D., Rehman, S. F., Bowerman, K. L., Keely, S., Hugenholtz, P., Armstrong-James, D. P. H., Adcock, I. M., Chotirmall, S. H., Chung, K. F., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30510-1 · Cited by 446
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Self-citationBafadhel, M., Peterson, S., De Blas, M. A., Calverley, P. M., Rennard, S. I., Richter, K., & Fagerås, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30006-7 · Cited by 442
The lung microbiome in moderate and severe chronic obstructive pulmonary disease
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047305 · Cited by 437
S. Antonopoulos, A., Margaritis, M., Lee, R., Channon, K., & Antoniades, C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504803 · Cited by 432
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Vollenweider, D. J., Jarrett, H., Steurer-Stey, C. A., Garcia-Aymerich, J., & Puhan, M. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010257 · Cited by 425
Singh, D., Papi, A., Corradi, M., Pavlišová, I., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Vestbo, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31354-x · Cited by 425
Self-citationVestbo, J., Papi, A., Corradi, M., Blazhko, V., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Singh, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30188-5 · Cited by 425
Self-citationLeuppi, J. D., Schuetz, P., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., et al. (2013) · JAMA · doi:10.1001/jama.2013.5023 · Cited by 424
Osadnik, C. R., Tee, V. S., Carson-Chahhoud, K. V., Picot, J., Wedzicha, J. A., & Smith, B. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004104.pub4 · Cited by 422
Self-citationChandra, D., Stamm, J. A., Taylor, B., Ramos, R. M., Satterwhite, L., Krishnan, J. A., Mannino, D., Sciurba, F. C., & Holguín, F. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-1094oc · Cited by 418
Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Self-citationSiddiqui, S. H., Guasconi, A., Vestbo, J., Jones, P., Agusti, A., Paggiaro, P., Wedzicha, J. A., & Singh, D. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0235le · Cited by 415
Self-citationInhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kew, K. M., & Seniukovich, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010115.pub2 · Cited by 398
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
Holguin, F., Folch, E., Redd, S. C., & Mannino, D. M. (2005) · Chest · doi:10.1378/chest.128.4.2005 · Cited by 396
Steer, J., Gibson, J., & Bourke, S. C. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202103 · Cited by 388
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
Confalonieri, M., Garuti, G., Cattaruzza, M. S., Osborn, J. F., Antonelli, M., Conti, G., Kodric, M., Resta, O., Marchese, S., Gregoretti, C., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00085304 · Cited by 378
Inflammatory changes, recovery and recurrence at COPD exacerbation
Perera, W. R., Hurst, J. R., Wilkinson, T. M. A., Sapsford, R. J., Müllerova, H., Donaldson, G. C., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092506 · Cited by 372
Self-citationConti, G., Antonelli, M., Navalesi, P., Rocco, M., Bufi, M., Spadetta, G., & Meduri, G. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1478-0 · Cited by 371
Enslein, K. (1978) · Technometrics · doi:10.1080/00401706.1978.10489655 · Cited by 362
Defective macrophage phagocytosis of bacteria in COPD
Taylor, A. E., Finney-Hayward, T. K., Quint, J. K., Thomas, C. M. R., Tudhope, S. J., Wedzicha, J. A., Barnes, P. J., & Donnelly, L. E. (2010) · European Respiratory Journal · doi:10.1183/09031936.00036709 · Cited by 359
Self-citationZheng, J.-P., Kang, J., Huang, S.-G., Chen, P., Yao, W.-Z., Yang, L., Bai, C.-X., Wang, C.-Z., Wang, C., Chen, B.-Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60869-7 · Cited by 358
Benralizumab for the Prevention of COPD Exacerbations
Criner, G. J., Celli, B. R., Brightling, C. E., Agusti, A., Papi, A., Singh, D., Sin, D. D., Vogelmeier, C. F., Sciurba, F. C., Bafadhel, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905248 · Cited by 351
Self-citationThe natural history of chronic bronchitis and emphysema
Wright, P. (1977) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(77)90115-2 · Cited by 348
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Criner, G. J., Connett, J. E., Aaron, S. D., Albert, R. K., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Curtis, J. L., Dransfield, M. T., Han, M. K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403086 · Cited by 347
Burgel, P.-R., Nesme-Meyer, P., Chanez, P., Caillaud, D., Carré, P., Perez, T., & Roche, N. (2009) · Chest · doi:10.1378/chest.08-2062 · Cited by 346
Incidence and causes of non-invasive mechanical ventilation failure after initial success
Moretti, M. (2000) · Thorax · doi:10.1136/thorax.55.10.819 · Cited by 327
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Self-citationUnderdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease
Diab, N., Gershon, A. S., Sin, D. D., Tan, W. C., Bourbeau, J., Boulet, L.-P., & Aaron, S. D. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0621ci · Cited by 324
Underreporting Exacerbation of Chronic Obstructive Pulmonary Disease in a Longitudinal Cohort
Langsetmo, L., Platt, R. W., Ernst, P., & Bourbeau, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1290oc · Cited by 319
Han, M. K., Quibrera, P. M., Carretta, E. E., Barr, R. G., Bleecker, E. R., Bowler, R. P., Cooper, C. B., Comellas, A., Couper, D. J., Curtis, J. L., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30207-2 · Cited by 319
Self-citationNici, L., Mammen, M. J., Charbek, E., Alexander, P. E., Au, D. H., Boyd, C. M., Criner, G. J., Donaldson, G. C., Dreher, M., Fan, V. S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0625st · Cited by 316
Self-citationTillie-Leblond, I., Marquette, C.-H., Perez, T., Scherpereel, A., Zanetti, C., Tonnel, A.-B., & Remy-Jardin, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00005 · Cited by 312
Fracture risk with intermittent high‐dose oral glucocorticoid therapy
De Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C., & Van Staa, T. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 298
Infectious Etiology of Acute Exacerbations of Chronic Bronchitis
Sethi, S. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.380s · Cited by 296
Greening, N. J., Williams, J. E. A., Hussain, S. F., Harvey-Dunstan, T. C., Bankart, M. J., Chaplin, E. J., Vincent, E. E., Chimera, R., Morgan, M. D., Singh, S. J., et al. (2014) · BMJ · doi:10.1136/bmj.g4315 · Cited by 289
Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis
Li, J., Sun, S., Tang, R., Qiu, H., Huang, Q., Mason, T., & Tian, L. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s122282 · Cited by 283
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Walters, J. A., Gibson, P. G., Wood-Baker, R., Hannay, M., & Walters, E. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001288.pub3 · Cited by 279
Decramer, M. L., Chapman, K. R., Dahl, R., Frith, P., Devouassoux, G., Fritscher, C., Cameron, R., Shoaib, M., Lawrence, D., Young, D., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70158-9 · Cited by 277
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
Butler, C. C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., Wootton, M., Hood, K., Phillips, R., Melbye, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803185 · Cited by 277
Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Quint, J. K., Goldring, J. J. P., Baghai-Ravary, R., & Wedzicha, J. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1067oc · Cited by 276
Self-citationNannini, L. J., Poole, P., Milan, S. J., Holmes, R., & Normansell, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub4 · Cited by 274
Mallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.-B., Kebadze, T., Aniscenko, J., Oleszkiewicz, G., Gray, K., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0806oc · Cited by 274
Self-citationLoke, Y. K., Cavallazzi, R., & Singh, S. (2011) · Thorax · doi:10.1136/thx.2011.160028 · Cited by 267
Djukanović, R., Harrison, T., Johnston, S. L., Gabbay, F., Wark, P., Thomson, N. C., Niven, R., Singh, D., Reddel, H. K., Davies, D. E., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2235oc · Cited by 266
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Bozinovski, S., Hutchinson, A., Thompson, M., MacGregor, L., Black, J., Giannakis, E., Karlsson, A.-S., Silvestrini, R., Smallwood, D., Vlahos, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-678oc · Cited by 260
Zheng, J.-P., Wen, F.-Q., Bai, C.-X., Wan, H.-Y., Kang, J., Chen, P., Yao, W.-Z., Ma, L.-J., Li, X., Raiteri, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70286-8 · Cited by 258
Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
Roversi, S., Fabbri, L. M., Sin, D. D., Hawkins, N. M., & Agustí, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0690so · Cited by 251
Self-citationChapman, K. R., Hurst, J. R., Frent, S.-M., Larbig, M., Fogel, R., Guerin, T., Banerji, D., Patalano, F., Goyal, P., Pfister, P., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201803-0405oc · Cited by 251
Self-citationAcidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations
Roberts, C. M., Stone, R. A., Buckingham, R. J., Pursey, N. A., Lowe, D., & On behalf of the National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project (NCROP) implementation group (2011) · Thorax · doi:10.1136/thx.2010.153114 · Cited by 233
Inhaled corticosteroids in COPD: friend or foe?
Agusti, A., Fabbri, L. M., Singh, D., Vestbo, J., Celli, B., Franssen, F. M. E., Rabe, K. F., & Papi, A. (2018) · European Respiratory Journal · doi:10.1183/13993003.01219-2018 · Cited by 229
Self-citationOutdoor air pollution and respiratory health in patients with COPD
Peacock, J. L., Anderson, H. R., Bremner, S. A., Marston, L., Seemungal, T. A., Strachan, D. P., & Wedzicha, J. A. (2011) · Thorax · doi:10.1136/thx.2010.155358 · Cited by 217
Self-citationTiotropium versus placebo for chronic obstructive pulmonary disease
Karner, C., Chong, J., & Poole, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009285.pub3 · Cited by 210
Mackay, A. J., Donaldson, G. C., Patel, A. R. C., Jones, P. W., Hurst, J. R., & Wedzicha, J. A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1843oc · Cited by 205
Self-citationLindenauer, P. K. (2010) · JAMA · doi:10.1001/jama.2010.796 · Cited by 196
Calverley, P. M. A., Anzueto, A. R., Carter, K., Grönke, L., Hallmann, C., Jenkins, C., Wedzicha, J., & Rabe, K. F. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30102-4 · Cited by 189
Self-citationWilkinson, T. M. A., Donaldson, G. C., Johnston, S. L., Openshaw, P. J. M., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1489oc · Cited by 187
Self-citationDel Sorbo, L., Pisani, L., Filippini, C., Fanelli, V., Fasano, L., Terragni, P., Dell’Amore, A., Urbino, R., Mascia, L., Evangelista, A., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000607 · Cited by 184
(2003) · Survey of Anesthesiology · doi:10.1097/00132586-200302000-00012 · Cited by 184
Leidy, N. K., Wilcox, T. K., Jones, P. W., Roberts, L., Powers, J. H., & Sethi, S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0762oc · Cited by 183
Metoprolol for the Prevention of Acute Exacerbations of COPD
Dransfield, M. T., Voelker, H., Bhatt, S. P., Brenner, K., Casaburi, R., Come, C. E., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Han, M. K., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908142 · Cited by 183
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Powrie, D. J., Wilkinson, T. M. A., Donaldson, G. C., Jones, P., Scrine, K., Viel, K., Kesten, S., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00023907 · Cited by 178
Self-citationBraune, S., Sieweke, A., Brettner, F., Staudinger, T., Joannidis, M., Verbrugge, S., Frings, D., Nierhaus, A., Wegscheider, K., & Kluge, S. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4452-y · Cited by 177
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Wrona, C., Eschberger, K., Lobbins, P., Cai, X., & Murphy, T. F. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1234oc · Cited by 176
Sivapalan, P., Lapperre, T. S., Janner, J., Laub, R. R., Moberg, M., Bech, C. S., Eklöf, J., Holm, F. S., Armbruster, K., Sivapalan, P., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30176-6 · Cited by 172
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Walters, J. A., Tan, D. J., White, C. J., Gibson, P. G., Wood-Baker, R., & Walters, E. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001288.pub4 · Cited by 170
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Contoli, M., Pauletti, A., Rossi, M. R., Spanevello, A., Casolari, P., Marcellini, A., Forini, G., Gnesini, G., Marku, B., Barnes, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00451-2017 · Cited by 169
Self-citationBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Bafadhel, M., Davies, L., Calverley, P. M. A., Aaron, S. D., Brightling, C. E., & Pavord, I. D. (2014) · European Respiratory Journal · doi:10.1183/09031936.00062614 · Cited by 167
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
Herath, S., & Poole, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009764.pub2 · Cited by 150
Long-acting beta2-agonists for chronic obstructive pulmonary disease
Kew, K. M., Mavergames, C., & Walters, J. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010177.pub2 · Cited by 149
Barr, R. G., Rowe, B. H., & Camargo, C. A. (2003) · BMJ · doi:10.1136/bmj.327.7416.643 · Cited by 142
Pinto-Plata, V., Livnat, G., Girish, M., Cabral, H., Masdin, P., Linacre, P., Dew, R., Kenney, L., & Celli, B. R. (2007) · CHEST Journal · doi:10.1378/chest.06-0668 · Cited by 141
Self-citationBlamoun, A. I., Batty, G. N., DeBari, V. A., Rashid, A., Sheikh, M., & Khan, M. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01731.x · Cited by 141
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Chong, J., & Cates, C. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub5 · Cited by 141
High flow nasal cannulae oxygen therapy in acute‐moderate hypercapnic respiratory failure
Lee, M. K., Choi, J., Park, B., Kim, B. J., Lee, S. J., Kim, S., Yong, S. J., Choi, E. H., & Lee, W. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12772 · Cited by 139
Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship
Goudis, C. A. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.12.013 · Cited by 137
Blood and sputum eosinophils in COPD; relationship with bacterial load
Kolsum, U., Donaldson, G. C., Singh, R., Barker, B. L., Gupta, V., George, L., Webb, A. J., Thurston, S., Brookes, A. J., McHugh, T. D., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0570-5 · Cited by 136
Self-citationWildman, M. J., Sanderson, C. F. B., Groves, J., Reeves, B. C., Ayres, J. G., Harrison, D. A., Young, D., & Rowan, K. (2007) · BMJ · doi:10.1136/bmj.39371.524271.55 · Cited by 135
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
Negro, R. W. D., Wedzicha, J. A., Iversen, M., Fontana, G. A., Page, C. P., Cicero, A. F. G., Pozzi, E., & Calverley, P. M. A. (2017) · European Respiratory Journal · doi:10.1183/13993003.00711-2017 · Cited by 134
Self-citationPneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
Walters, J. A., Tang, J., Poole, P., & Wood-Baker, R. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub4 · Cited by 131
Nannini, L. J., Cates, C. J., Lasserson, T. J., & Poole, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006829 · Cited by 129
Epidemiological relationships between the common cold and exacerbation frequency in COPD
Hurst, J. R., Donaldson, G. C., Wilkinson, T. M. A., Perera, W. R., & Wedzicha, J. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00043405 · Cited by 127
Self-citationβ-Blockers are associated with a reduction in COPD exacerbations
Bhatt, S. P., Wells, J. M., Kinney, G. L., Washko, G. R., Budoff, M. J., Kim, Y.-I., Bailey, W. C., Nath, H. P., Hokanson, J. E., Silverman, E. K., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207251 · Cited by 127
Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Restrepo, M. I., Sibila, O., & Anzueto, A. (2018) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2018.0030 · Cited by 127
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Vollenweider, D. J., Frei, A. L., Steurer-Stey, C. A., García‐Aymerich, J., & Puhan, M. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010257.pub2 · Cited by 126
Bacterial microbiome of lungs in COPD
Sin, D. D., Sze, M. A., & Hogg, J. C. (2014) · International Journal of COPD · doi:10.2147/copd.s38932 · Cited by 125
Aaron, S. D., Vandemheen, K. L., Clinch, J., Ahuja, J., Brison, R. J., Dickinson, G. E., & Hébert, P. C. (2002) · CHEST Journal · doi:10.1378/chest.121.3.688 · Cited by 124
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
Kopsaftis, Z., Wood-Baker, R. R., & Poole, P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002733.pub3 · Cited by 119
Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?
Rutschmann, O. T., Cornuz, J., Poletti, P., Bridevaux, P., Hügli, O., Qanadli, S. D., & Perrier, A. (2006) · Thorax · doi:10.1136/thx.2006.065557 · Cited by 117
Alía, I. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.530 · Cited by 112
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
Herath, S., Normansell, R., Maisey, S., & Poole, P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009764.pub3 · Cited by 111
The biology of pulmonary exacerbations in bronchiectasis
Amati, F., Simonetta, E., Gramegna, A., Tarsia, P., Contarini, M., Blasi, F., & Aliberti, S. (2019) · European Respiratory Review · doi:10.1183/16000617.0055-2019 · Cited by 109
Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations
Wedzicha, J. A., Singh, D., Vestbo, J., Paggiaro, P., Jones, P., Bonnet-Gonod, F., Cohuet, G., Corradi, M., Vezzoli, S., Petruzzelli, S., et al. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.05.013 · Cited by 108
Self-citationEpidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
Lahousse, L., Seys, L., Joos, G., Franco, O. H., Stricker, B. H. C., & Brusselle, G. (2017) · European Respiratory Journal · doi:10.1183/13993003.02470-2016 · Cited by 104
TNFα Antagonists for Acute Exacerbations of COPD: A Randomised Double-Blind Controlled Trial
Aaron, S. D., Vandemheen, K. L., Maltais, F., Field, S. K., Sin, D. D., Bourbeau, J., Marciniuk, D. D., FitzGerald, J. M., Nair, P., & Mallick, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202432 · Cited by 103
Keenan, S., Powers, C. E., & McCormack, D. G. (2005) · Respiratory Care · doi:10.4187/respcare.05500610 · Cited by 98
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Beghé, B., Verduri, A., Roca, M., & Fabbri, L. M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00180812 · Cited by 97
Self-citationCRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions
Prins, H. J., Duijkers, R., van der Valk, P., Schoorl, M., Daniels, J. M. A., van der Werf, T. S., & Boersma, W. G. (2019) · European Respiratory Journal · doi:10.1183/13993003.02014-2018 · Cited by 97
Sivapalan, P., Ingebrigtsen, T. S., Rasmussen, D. B., Sørensen, R., Rasmussen, C. M., Jensen, C. B., Allin, K. H., Eklöf, J. V., Seersholm, N. J., Vestbo, J., et al. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2019-000407 · Cited by 96
Tan, W. C., Hague, C. J., Leipsic, J. A., Bourbeau, J., Zheng, L., Li, P. Z., Sin, D. D., Coxson, H. O., Kirby, M., Hogg, J. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166745 · Cited by 92
High flow through nasal cannula in exacerbated COPD patients: a systematic review
Pisani, L., Astuto, M., Prediletto, I., & Longhini, F. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2019.08.001 · Cited by 92
Miravitlles, M., Moragas, A., Hernandez, S. F., Bayona, C., & Llor, C. (2013) · CHEST Journal · doi:10.1378/chest.13-0518 · Cited by 91
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Soler, N., Esperatti, M., Ewig, S., Huerta, A. H., Agustí, C., & Torres, A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00150211 · Cited by 90
Beeh, K. M., Burgel, P., Franssen, F. M. E., López-Campos, J. L., Loukides, S., Hurst, J. R., Fležar, M., Ulrik, C. S., Marco, F. D., Stolz, D., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1794ci · Cited by 87
Self-citationPhosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease
Janjua, S., Normansell, R., & Poole, P. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub6 · Cited by 87
Long-acting beta2-agonists for chronic obstructive pulmonary disease
Karner, C., & Stovold, E. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010177 · Cited by 86
Mackay, A. J., Donaldson, G. C., Patel, A. R. C., Singh, R., Kowlessar, B. S., & Wedzicha, J. A. (2013) · European Respiratory Journal · doi:10.1183/09031936.00110913 · Cited by 86
Self-citationKiser, T. H., Allen, R. R., Valuck, R. J., Moss, M., & Vandivier, R. W. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0058oc · Cited by 85
Characterizing and Quantifying the Symptomatic Features of COPD Exacerbations
Jones, P., Chen, W.-H., Wilcox, T. K., Sethi, S., & Leidy, N. K. (2010) · CHEST Journal · doi:10.1378/chest.10-1240 · Cited by 81
Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation
Abroug, F., Ouanes-Besbes, L., Hassen, M. F., Ouanes, I., Ayed, S., Dachraoui, F., Brochard, L. J., & Elatrous, S. (2013) · European Respiratory Journal · doi:10.1183/09031936.00002913 · Cited by 79
Antiviral immunity is impaired in COPD patients with frequent exacerbations
Singanayagam, A., Loo, S.-L., Calderazzo, M. A., Finney, L., Torralbo, M.-B. T., Bakhsoliani, E., Girkin, J. L. N., Veerati, P. C., Pathinayake, P. S., Nichol, K., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00253.2019 · Cited by 79
Treatable traits in acute exacerbations of chronic airway diseases
McDonald, V. M., Osadnik, C. R., & Gibson, P. G. (2019) · Chronic Respiratory Disease · doi:10.1177/1479973119867954 · Cited by 78
Vermeersch, K., Gabrovska, M., Aumann, J. L., Demedts, I., Corhay, J.-L., Marchand, É., Slabbynck, H., Haenebalcke, C., Haerens, M., Hanon, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201901-0094oc · Cited by 76
Heart failure and chronic obstructive pulmonary disease: a review
Horodinschi, R.-N., Bratu, O. G., Dediu, G. N., Stoian, A. P., Motofei, I. G., & Diaconu, C. C. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1559485 · Cited by 75
Overdiagnosis of COPD in Subjects With Unobstructed Spirometry
Sator, L., Horner, A., Studnicka, M., Lamprecht, B., Kaiser, B., McBurnie, M. A., Buist, A. S., Gnatiuc, L., Mannino, D. M., Janson, C., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.015 · Cited by 75
Malik, A., & Batra, J. K. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.645519 · Cited by 72
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review
Hawkins, N. M., Khosla, A., Virani, S., McMurray, J. J. V., & FitzGerald, J. M. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0345-7 · Cited by 70
Serial studies of 100 patients with chronic airway obstruction in London and Chicago
Jones, N. L., Burrows, B. A., & Fletcher, C. M. (1967) · Thorax · doi:10.1136/thx.22.4.327 · Cited by 69
COPD and acute myocardial infarction
Goedemans, L., Bax, J. J., & Delgado, V. (2020) · European Respiratory Review · doi:10.1183/16000617.0139-2019 · Cited by 69
Mallia, P., Contoli, M., Caramori, G., Pandit, A., Johnston, S. L., & Papi, A. A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313777 · Cited by 67
Self-citationBewley, M. A., Belchamber, K. B. R., Chana, K. K., Budd, R. C., Donaldson, G., Wedzicha, J. A., Brightling, C. E., Kilty, I., Donnelly, L. E., Barnes, P. J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163139 · Cited by 64
Self-citationBhatt, S. P., Wells, J. M., Iyer, A. S., Kirkpatrick, D., Parekh, T. M., Leach, L., Anderson, E. M., Sanders, J. G., Nichols, J. K., Blackburn, C. C., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-775bc · Cited by 64
Idiopathische Lungenfibrose – Epidemiologie, Ursachen und klinischer Verlauf
Schäfer, S. C., Funke-Chambour, M., & Berezowska, S. (2020) · Der Pathologe · doi:10.1007/s00292-019-00747-x · Cited by 62
Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
López-Campos, J. L., Hartl, S., Pozo-Rodriguez, F., Roberts, C. M., & on behalf of the European COPD Audit team (2015) · PLOS ONE · doi:10.1371/journal.pone.0124374 · Cited by 59
Janjua, S., Pike, K. C., Carr, R., Coles, A., Normansell, R., & Batavia, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013381.pub2 · Cited by 59
Bacterial microbiome of lungs in COPD
Sze, M., Sze, M. A., Hogg, J. C., et al. (2016) · Cited by 59
Leidy, N. K., Murray, L. T., Jones, P., & Sethi, S. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201309-305oc · Cited by 57
Wildman, M. J., Sanderson, C. F. B., Groves, J., Reeves, B. C., Ayres, J. G., Harrison, D. A., Young, D., & Rowan, K. (2008) · Thorax · doi:10.1136/thx.2007.091249 · Cited by 54
Building toolkits for COPD exacerbations: lessons from the past and present
Sapey, E., Bafadhel, M., Bolton, C. E., Wilkinson, T. M. A., Hurst, J. R., & Quint, J. K. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-213035 · Cited by 52
Miravitlles, M., García-Sidro, P., Fernández-Nistal, A., Buendía, M. J., Monteros, M. J. E. D. L., & Molina, J. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-147 · Cited by 51
Tiotropium versus placebo for chronic obstructive pulmonary disease
Karner, C., Chong, J., & Poole, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009285 · Cited by 49
Statins versus placebo for people with chronic obstructive pulmonary disease
Walsh, A., Perrem, L., Khashan, A. S., Henry, M. T., & Chróinín, M. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011959.pub2 · Cited by 48
Non–anti-infective Effects of Antimicrobials and Their Clinical Applications
Sadarangani, S. P., Estes, L. L., & Steckelberg, J. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.09.006 · Cited by 45
Pfeffer, P., Donaldson, G. C., Mackay, A. J., & Wedzicha, J. A. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2506oc · Cited by 42
Self-citationSigns and symptoms in adult patients with acute dyspnea: a systematic review and meta-analysis
Renier, W., Winckelmann, K. H.-V., Verbakel, J. Y. J., Aertgeerts, B., & Buntinx, F. (2017) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000000429 · Cited by 41
Wang, & Chen (2005) · 中华医学杂志:英文版 · Cited by 40
Horsley, A. R., & Jones, A. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009529 · Cited by 40
Ni, W., Bao, J., Yang, D., Xi, W., Wang, K., Xu, Y., Zhang, R., & Gao, Z. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1644456 · Cited by 36
Mackay, A. J., Κostikas, Κ., Murray, L. T., Martínez, F. J., Miravitlles, M., Donaldson, G. C., Banerji, D. D., Patalano, F., & Wedzicha, J. A. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2482ci · Cited by 33
Self-citationLaue, J., Melbye, H., & Risør, M. B. (2017) · BMC Family Practice · doi:10.1186/s12875-017-0582-8 · Cited by 32
Jurjević, M., Matić, I., Šakić-Zdravčević, K., Šakić, Š., Đanić, D., & Buković, D. (2009) · PubMed · Cited by 31
Incidence and Impact of Pulmonary Embolism During Severe COPD Exacerbation
Hassen, M. F., Tilouche, N., Jaoued, O., & Elatrous, S. (2019) · Respiratory Care · doi:10.4187/respcare.06661 · Cited by 31
Dentali, F., Pomero, F., Micco, P. D., Regina, M. L., Landini, F., Mumoli, N., Pieralli, F., Giorgi‐Pierfranceschi, M., Re, R., Vitale, J., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.006 · Cited by 30
Self-citationThe Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. H., & Isaacson, R. E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-178mg · Cited by 27
Metadata
- Authors
- MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M.
- Venue
- Respirology
- Publisher
- Wiley
- Published
- 2021-04-24
- Volume
- 26
- Issue
- 6
- Pages
- 532-551
- ISSN
- 1323-7799 (ISSN-L)
- 1440-1843
- OpenAlex
- W3156431662
- Cited by
- 359
- References
- 207
- FWCI
- 23.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.